Building upon previous research, mainly in the field of inflammatory bowel disease (IBD), a team of researchers from Brazil, led by Pimentel et al., sought to evaluate Anti-Infliximab Antibodies (ADA) in patients with AS. This evidence concerns the gene ADA and inflammatory bowel disease.